These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4902494)

  • 1. Critical study of 5 per cent guanethidine in ocular manifestations of Graves's disease.
    Cartlidge NE; Crombie AL; Anderson J; Hall R
    Br Med J; 1969 Dec; 4(5684):645-7. PubMed ID: 4902494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Action of 5 per cent guanethidine sulfate (ismeline) eye drops on lid retraction during Basedow's disease].
    Storch J
    Ann Ocul (Paris); 1971 Jun; 204(6):627-44. PubMed ID: 5109312
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction.
    Crombie AL; Lawson AA
    Br Med J; 1967 Dec; 4(5579):592-5. PubMed ID: 6060118
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ocular manifestations of Basedow's disease and local administration of guanethidine].
    Berkman N; Joseph E
    Presse Med (1893); 1971 Jan; 79(3):83-6. PubMed ID: 5107433
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of guanethidine eyedrops on the ocular manifestations of Basedow's disease].
    Berkman N; Joseph E
    Arch Ophtalmol Rev Gen Ophtalmol; 1971; 31(8):617-28. PubMed ID: 4256931
    [No Abstract]   [Full Text] [Related]  

  • 6. Dysthyroid eye disease. A trial of guanethidine eye drops.
    Bowden AN; Rose FC
    Br J Ophthalmol; 1969 Apr; 53(4):246-51. PubMed ID: 4889097
    [No Abstract]   [Full Text] [Related]  

  • 7. Unwanted pharmacological effects of local guanethidine in the treatment of dysthyroid upper lid retraction.
    Cant JS; Lewis DR
    Br J Ophthalmol; 1969 Apr; 53(4):239-45. PubMed ID: 5818670
    [No Abstract]   [Full Text] [Related]  

  • 8. Mueller's muscle: to relax or to incise.
    Haddad HM
    Metab Pediatr Syst Ophthalmol (1985); 1995; 18(1-4):15-8. PubMed ID: 9064490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of dysthyroid ophthalmopathy with local guanethidine.
    Cant JS; Lewis DR; Harrison MT
    Br J Ophthalmol; 1969 Apr; 53(4):233-8. PubMed ID: 5818669
    [No Abstract]   [Full Text] [Related]  

  • 10. Spastic and paralytic types of lid retraction in Graves's disease.
    RUNDLE FF
    Med J Aust; 1953 Oct; 2(16):605-8. PubMed ID: 13110450
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of subgroups of euthyroid graves's ophthalmopathy.
    Solomon DH; Chopra IJ; Chopra U; Smith FJ
    N Engl J Med; 1977 Jan; 296(4):181-6. PubMed ID: 576175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Werner's classification of ocular changes in Graves's disease: a review.
    Lyle WM
    Am J Optom Physiol Opt; 1978 Feb; 55(2):119-27. PubMed ID: 354401
    [No Abstract]   [Full Text] [Related]  

  • 13. Guanethidine ophthalmic solution 5 per cent. Use in the treatment of endocrine exophthalmos.
    Asregadoo ER
    Arch Ophthalmol; 1970 Jul; 84(1):21-4. PubMed ID: 4912585
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of guanethidine eye drops in dysthyroid lid retraction.
    Martin B; Jay B
    Proc R Soc Med; 1969 Jan; 62(1):18-9. PubMed ID: 5763459
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind clinical trial of a guanethidine/adrenaline combination, compared with the two separate components, in glaucoma.
    Eltz H; Aeschlimann J; Gloor B
    Acta Ophthalmol (Copenh); 1978 Apr; 56(2):191-200. PubMed ID: 352088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic trial of the combination in an eye lotion of adrenaline (0.5 or 1%) and guanethidine (3 or 5%) in cases of open-angle glaucoma.
    Bardy M
    Ophthalmologica; 1979; 178(1-2):49-55. PubMed ID: 375150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
    Hu YM; Liu W; Lu GH
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experiences with guanethidine in the treatment of hyperthyroidism].
    Laubinger G
    Med Welt; 1967 May; 21():1316-9. PubMed ID: 5612543
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of adrenaline and guanethidine in reducing intraocular pressure in rabbits' eyes.
    Jones DE; Norton DA; Harvey J; Davies DJ
    Br J Ophthalmol; 1975 Jun; 59(6):304-7. PubMed ID: 1174485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of guanethidine in preventing the retraction of the upper lid in Graves' disease].
    Chwirot R; Gliński J
    Klin Oczna; 1972; 42(3):883-4. PubMed ID: 5067657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.